Will the launch of Favipiravir mark the turnaround for Glenmark Pharma?

If the drug proves to be efficacious for Covid treatment, Glenmark
will enjoy first mover advantage.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/will-the-launch-of-favipiravir-mark-the-turnaround-for-glenmark-pharma/articleshow/76498905.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment